|

|
ART & PREGNANCY
|
|

|
 |
last updated: May 4, 2001
|

|

|
COMPLETE GUIDELINES:
|

|

|
html
pdf
selected tables
panel members
|

|

|
RELATED INFORMATION:
|

|

|
faqs news links
|

|

|
| TABLE
5. Rate of perinatal transmission according to receipt of zidovudine
during pregnancy and mode of delivery |
|
|
Transmission
Rate |
|
|
Study
design (reference)
|
Therapy
|
Elective
CS
|
Other
modes
|
Odds
ratio (95% Cl)
|
|
Observational
data (128)
|
No
ZDV
|
58/559 (10.4%)
|
1021/5385
(19%)
|
0.49 (0.4-0.7)
|
|
ZDV
|
4/196 (2%)
|
92/1255
(7.3%)
|
0.26 (0.07-0.7)
|
|
Randomized
trial (129)
|
No
ZDV
|
2/51
(4%)
|
16/82
(20%)
|
0.20
(0-0.8)
|
|
ZDV
|
1/119 (1%)
|
5/117
(4%)
|
0.20
(0- 1.7)
|

|

|

|
|
|
|